JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Corteva (NYSE:CTVA) Stock

Corteva (NYSE:CTVA) had its price target increased by investment analysts at JPMorgan Chase & Co. from $77.00 to $83.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 6.00% from the stock’s previous close.

Several other equities analysts have also recently issued reports on the company. Royal Bank Of Canada raised their price objective on Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Corteva in a report on Monday. CICC Research raised their price target on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Rothschild & Co Redburn lifted their price target on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Finally, Wells Fargo & Company boosted their price objective on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $91.14.

Corteva Stock Down 0.5%

NYSE CTVA traded down $0.41 on Monday, hitting $78.30. 1,985,799 shares of the stock traded hands, compared to its average volume of 4,005,341. The stock has a 50-day moving average of $82.15 and a 200 day moving average of $79.63. Corteva has a twelve month low of $60.53 and a twelve month high of $90.97. The company has a market capitalization of $52.37 billion, a P/E ratio of 51.91, a price-to-earnings-growth ratio of 2.39 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. During the same quarter last year, the firm earned $2.20 EPS. The business’s revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, analysts expect that Corteva will post 3.75 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Drummond Knight Asset Management Pty Ltd acquired a new stake in Corteva in the fourth quarter worth about $25,713,000. Arbejdsmarkedets Tillaegspension bought a new position in Corteva in the 4th quarter valued at about $23,679,000. Leonteq Securities AG acquired a new position in Corteva during the 4th quarter valued at about $2,350,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Corteva by 23.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock worth $7,378,000 after buying an additional 20,957 shares in the last quarter. Finally, Brandes Investment Partners LP boosted its holdings in shares of Corteva by 1.1% in the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock valued at $155,009,000 after acquiring an additional 24,985 shares in the last quarter. 81.54% of the stock is owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.